Amit Bakshi
Healthcare
ChrysCapital injects more funds into drugmaker after returning as investor
Homegrown private equity firm ChrysCapital has pumped additional capital into a pharmaceutical company, barely weeks after coming on board again ......
Healthcare
ChrysCapital returns as investor in another pharma firm after taking it public
Homegrown private equity firm ChrysCapital has returned to invest in a pharmaceutical company that it had helped launch on the ......
Healthcare
Eris Lifesciences buys anti-diabetic drug from Novartis for India market
Eris Lifesciences Ltd said it has acquired the trademark for anti-diabetic drug Zomelis for $13 million (Rs 92.9 crore) from ......
Finance
Indian IPO markets have become deeper: NSE Tech Conclave
Indian primary capital markets have become deeper and have proved to be an attractive exit mechanism for private equity and ......
Healthcare
Eris Lifesciences ends below IPO price in trading debut
Drugmaker Eris Lifesciences Ltd made a tepid debut on the stock exchanges on Thursday with its shares closing in the ......
Healthcare
ChrysCapital explores exit from Eris Lifesciences
Private equity firm ChrysCapital is exploring options to exit Ahmedabad-based pharmaceutical company Eris Lifesciences Pvt. Ltd, two people familiar with ......
Others
Keynote address by Piruz Khambatta of Rasna & more at VCCircle Ahmedabad Investment Forum 2012: Register now
Rasna, India’s local entrepreneurial story, was launched as a brand in the mid-70s but started gaining popularity in the 80s ......
